Immune Design Corp. | Key People and Executives
Carlos V. Paya
President, Chief Executive Officer & Director
Susan L. Kelley
Independent Director
Lewis W. Coleman
Independent Director
Franklin M. Berger
Independent Director
Bill R. Ringo
Independent Director
David Baltimore
Independent Director
Carlos V. Paya
President, Chief Executive Officer & Director
Sergey Yurasov
Chief Medical Officer & SVP-Clinical Development
Jan Henrik ter Meulen
Chief Scientific Officer
Stephen R. Brady
Executive Vice President-Strategy & Finance
Sandy Mohan
Vice President-Quality & Compliance
Frank J. Hsu
Vice President & Head-Oncology
Wayne R. Gombotz
Chief Development Officer
Sylvia R. Wheeler
Investor Contact
Heidi Petersen
Vice President-Regulatory Affairs
Susan L. Kelley
Independent Director
Lewis W. Coleman
Independent Director
Franklin M. Berger
Independent Director
Bill R. Ringo
Independent Director
David Baltimore
Independent Director
| Address |
1616 Eastlake Avenue East
Seattle Washington 98102
United States
|
|
Employees
|
- |
| Website |
http://www.immunedesign.com |
| Updated |
09/14/2018 |
| Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. |
